Citadel Advisors - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 112 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$11,714,000
+360.6%
490,089
+181.4%
0.00%
Q4 2020$2,543,000
-67.0%
174,157
-67.9%
0.00%
-100.0%
Q3 2020$7,696,000
-3.0%
542,000
+0.5%
0.00%
-33.3%
Q2 2020$7,936,000
+7386.8%
539,541
+1995.1%
0.00%
Q1 2020$106,000
-86.6%
25,752
-84.3%
0.00%
Q4 2019$790,000
-64.7%
164,211
-55.6%
0.00%
-100.0%
Q3 2019$2,240,000
+21.5%
369,515
+30.1%
0.00%0.0%
Q2 2019$1,844,000
-12.3%
284,065
-4.2%
0.00%0.0%
Q1 2019$2,102,000
+246.3%
296,385
+137.1%
0.00%
Q4 2018$607,000
+318.6%
124,999
+531.3%
0.00%
Q3 2018$145,000
-82.1%
19,801
-84.4%
0.00%
Q2 2018$808,000
+125.7%
126,784
+92.7%
0.00%
Q1 2018$358,000
+6.5%
65,793
-18.4%
0.00%
Q4 2017$336,000
-60.4%
80,609
-8.5%
0.00%
-100.0%
Q3 2017$848,000
-92.4%
88,143
-90.6%
0.00%
-88.9%
Q2 2017$11,088,000
+10.4%
937,337
+19.6%
0.01%0.0%
Q1 2017$10,048,000
+115.5%
783,765
+105.7%
0.01%
+80.0%
Q4 2016$4,662,000
+312.2%
380,933
+297.5%
0.01%
+400.0%
Q3 2016$1,131,000
-77.9%
95,827
-77.2%
0.00%
-87.5%
Q3 2013$5,108,000420,4010.01%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders